Intensive Care Medicine, ISSN 0342-4642, 10/2013, Volume 39, Issue 10, pp. 1683 - 1694
Parenteral lipid emulsions (LEs) are commonly rich in long-chain triglycerides derived from soybean oil (SO). SO-containing emulsions may promote systemic...
Pediatrics | Pain Medicine | Emergency Medicine | Pneumology/Respiratory System | Medicine & Public Health | Soybean oil reducing strategies | Critically ill | Intensive / Critical Care Medicine | Alternative lipid emulsions | Anesthesiology | SURGICAL-PATIENTS | RANDOMIZED CONTROLLED-TRIAL | MEDIUM-CHAIN TRIGLYCERIDES | TOTAL PARENTERAL-NUTRITION | SOYBEAN OIL EMULSION | DOUBLE-BLIND | POLYUNSATURATED FATTY-ACIDS | CARE-UNIT PATIENTS | FISH-OIL | SEVERE ACUTE-PANCREATITIS | CRITICAL CARE MEDICINE | Lecithins - administration & dosage | Emulsions - therapeutic use | Fat Emulsions, Intravenous - adverse effects | Immune System - physiology | Emulsions - adverse effects | Humans | Oxidative Stress - physiology | Fat Emulsions, Intravenous - chemistry | Fish Oils - adverse effects | Safflower Oil - administration & dosage | Fish Oils - therapeutic use | Emulsions - administration & dosage | Parenteral Nutrition - methods | Soybean Oil - administration & dosage | Adult | Fish Oils - administration & dosage | Triglycerides - therapeutic use | Databases, Bibliographic | Plant Oils - administration & dosage | Phospholipids - therapeutic use | Triglycerides - adverse effects | Phospholipids - adverse effects | Safflower Oil - adverse effects | Intensive Care Units | Lecithins - adverse effects | Parenteral Nutrition - adverse effects | Safflower Oil - therapeutic use | Phospholipids - administration & dosage | Lecithins - therapeutic use | Treatment Outcome | Soybean Oil - therapeutic use | Inflammation - etiology | Plant Oils - therapeutic use | Plant Oils - adverse effects | Randomized Controlled Trials as Topic | Soybean Oil - adverse effects | Triglycerides - administration & dosage | Immune System - drug effects | Critical Illness - therapy | Inflammation - prevention & control | Oxidative Stress - drug effects | Fat Emulsions, Intravenous - therapeutic use | Care and treatment | Research | Health aspects | Soy oil | critically ill | alternative lipid emulsions | soybean oil reducing strategies
Pediatrics | Pain Medicine | Emergency Medicine | Pneumology/Respiratory System | Medicine & Public Health | Soybean oil reducing strategies | Critically ill | Intensive / Critical Care Medicine | Alternative lipid emulsions | Anesthesiology | SURGICAL-PATIENTS | RANDOMIZED CONTROLLED-TRIAL | MEDIUM-CHAIN TRIGLYCERIDES | TOTAL PARENTERAL-NUTRITION | SOYBEAN OIL EMULSION | DOUBLE-BLIND | POLYUNSATURATED FATTY-ACIDS | CARE-UNIT PATIENTS | FISH-OIL | SEVERE ACUTE-PANCREATITIS | CRITICAL CARE MEDICINE | Lecithins - administration & dosage | Emulsions - therapeutic use | Fat Emulsions, Intravenous - adverse effects | Immune System - physiology | Emulsions - adverse effects | Humans | Oxidative Stress - physiology | Fat Emulsions, Intravenous - chemistry | Fish Oils - adverse effects | Safflower Oil - administration & dosage | Fish Oils - therapeutic use | Emulsions - administration & dosage | Parenteral Nutrition - methods | Soybean Oil - administration & dosage | Adult | Fish Oils - administration & dosage | Triglycerides - therapeutic use | Databases, Bibliographic | Plant Oils - administration & dosage | Phospholipids - therapeutic use | Triglycerides - adverse effects | Phospholipids - adverse effects | Safflower Oil - adverse effects | Intensive Care Units | Lecithins - adverse effects | Parenteral Nutrition - adverse effects | Safflower Oil - therapeutic use | Phospholipids - administration & dosage | Lecithins - therapeutic use | Treatment Outcome | Soybean Oil - therapeutic use | Inflammation - etiology | Plant Oils - therapeutic use | Plant Oils - adverse effects | Randomized Controlled Trials as Topic | Soybean Oil - adverse effects | Triglycerides - administration & dosage | Immune System - drug effects | Critical Illness - therapy | Inflammation - prevention & control | Oxidative Stress - drug effects | Fat Emulsions, Intravenous - therapeutic use | Care and treatment | Research | Health aspects | Soy oil | critically ill | alternative lipid emulsions | soybean oil reducing strategies
Journal Article
JAMA, ISSN 0098-7484, 11/2012, Volume 308, Issue 19, pp. 2001 - 2011
CONTEXT Postoperative atrial fibrillation or flutter (AF) is one of the most common complications of cardiac surgery and significantly increases morbidity and...
SUPPLEMENTATION | MEDICINE, GENERAL & INTERNAL | ARTERY-BYPASS SURGERY | GUIDELINES | DOUBLE-BLIND | POLYUNSATURATED FATTY-ACIDS | RISK | RECURRENCE | DEATH | ASSOCIATION | ELECTRICAL CARDIOVERSION | Double-Blind Method | Humans | Middle Aged | Male | Risk | Treatment Outcome | Cardiovascular Surgical Procedures - adverse effects | Fish Oils - therapeutic use | Atrial Fibrillation - etiology | Fatty Acids, Omega-3 - therapeutic use | Female | Aged | Odds Ratio | Dietary Supplements | Atrial Fibrillation - prevention & control | Care and treatment | Usage | Diet therapy | Fish oils | Atrial fibrillation | Dietary supplements | Management | Health aspects | Postoperative care | Omega-3 fatty acids | Surgical outcomes | Cardiac arrhythmia | Postoperative period | Heart surgery | Fatty acids | Risk assessment
SUPPLEMENTATION | MEDICINE, GENERAL & INTERNAL | ARTERY-BYPASS SURGERY | GUIDELINES | DOUBLE-BLIND | POLYUNSATURATED FATTY-ACIDS | RISK | RECURRENCE | DEATH | ASSOCIATION | ELECTRICAL CARDIOVERSION | Double-Blind Method | Humans | Middle Aged | Male | Risk | Treatment Outcome | Cardiovascular Surgical Procedures - adverse effects | Fish Oils - therapeutic use | Atrial Fibrillation - etiology | Fatty Acids, Omega-3 - therapeutic use | Female | Aged | Odds Ratio | Dietary Supplements | Atrial Fibrillation - prevention & control | Care and treatment | Usage | Diet therapy | Fish oils | Atrial fibrillation | Dietary supplements | Management | Health aspects | Postoperative care | Omega-3 fatty acids | Surgical outcomes | Cardiac arrhythmia | Postoperative period | Heart surgery | Fatty acids | Risk assessment
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 2012, Issue 2, p. CD005205
Background Many people with atopic eczema are reluctant to use the most commonly recommended treatments because they fear the long-term health effects. As a...
UNITED-STATES | VITAMIN-D | CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | PULP OILS | DERMATITIS | DOUBLE-BLIND | REVISED NOMENCLATURE | FATTY-ACIDS | HEALTH-CARE | HIPPOPHAE-RHAMNOIDES SEED | Selenium - therapeutic use | Humans | Dermatitis, Atopic - diet therapy | Pyridoxine - therapeutic use | Vitamin E - therapeutic use | Vitamin D - therapeutic use | Vitamins - therapeutic use | Dietary Supplements | Plant Oils - therapeutic use | Zinc - therapeutic use | Fish Oils - therapeutic use | Randomized Controlled Trials as Topic
UNITED-STATES | VITAMIN-D | CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | PULP OILS | DERMATITIS | DOUBLE-BLIND | REVISED NOMENCLATURE | FATTY-ACIDS | HEALTH-CARE | HIPPOPHAE-RHAMNOIDES SEED | Selenium - therapeutic use | Humans | Dermatitis, Atopic - diet therapy | Pyridoxine - therapeutic use | Vitamin E - therapeutic use | Vitamin D - therapeutic use | Vitamins - therapeutic use | Dietary Supplements | Plant Oils - therapeutic use | Zinc - therapeutic use | Fish Oils - therapeutic use | Randomized Controlled Trials as Topic
Journal Article
JAMA Internal Medicine, ISSN 2168-6106, 02/2017, Volume 177, Issue 2, pp. 184 - 193
IMPORTANCE: Vascular access dysfunction is a leading cause of morbidity and mortality in patients requiring hemodialysis. Arteriovenous fistulae are preferred...
MEDICINE, GENERAL & INTERNAL | METAANALYSIS | THROMBOSIS | OMEGA-3-FATTY-ACIDS | CARDIOVASCULAR-DISEASE | DOUBLE-BLIND | RISK | FATTY-ACIDS | CHRONIC KIDNEY-DISEASE | VASCULAR ACCESS OUTCOMES | PATENCY | Constriction, Pathologic - prevention & control | Double-Blind Method | Administration, Oral | Arteriovenous Shunt, Surgical | Humans | Middle Aged | Graft Occlusion, Vascular - prevention & control | Male | Treatment Outcome | Vascular Patency - drug effects | Fish Oils - therapeutic use | Kidney Failure, Chronic - therapy | Fibrinolytic Agents - therapeutic use | Adult | Female | Aspirin - therapeutic use | Dietary Supplements | Renal Dialysis | Care and treatment | Aspirin | Usage | Fish oils | Hemodialysis | Patient outcomes | Fistula, Arteriovenous | Dosage and administration | Health aspects
MEDICINE, GENERAL & INTERNAL | METAANALYSIS | THROMBOSIS | OMEGA-3-FATTY-ACIDS | CARDIOVASCULAR-DISEASE | DOUBLE-BLIND | RISK | FATTY-ACIDS | CHRONIC KIDNEY-DISEASE | VASCULAR ACCESS OUTCOMES | PATENCY | Constriction, Pathologic - prevention & control | Double-Blind Method | Administration, Oral | Arteriovenous Shunt, Surgical | Humans | Middle Aged | Graft Occlusion, Vascular - prevention & control | Male | Treatment Outcome | Vascular Patency - drug effects | Fish Oils - therapeutic use | Kidney Failure, Chronic - therapy | Fibrinolytic Agents - therapeutic use | Adult | Female | Aspirin - therapeutic use | Dietary Supplements | Renal Dialysis | Care and treatment | Aspirin | Usage | Fish oils | Hemodialysis | Patient outcomes | Fistula, Arteriovenous | Dosage and administration | Health aspects
Journal Article
Journal of the American Veterinary Medical Association, ISSN 0003-1488, 12/2011, Volume 239, Issue 11, pp. 1441 - 1451
MATRIX METALLOPROTEINASES | EVENING PRIMROSE OIL | MAMMARY-TUMORS | DIETARY SUPPLEMENTATION | MILIARY DERMATITIS | HEART-FAILURE | DOGS | JOINT DISEASE | POLYUNSATURATED FATTY-ACIDS | VETERINARY SCIENCES | RENAL-INSUFFICIENCY | Cats | Animals | Dog Diseases - drug therapy | Dogs | Fatty Acids, Omega-3 - therapeutic use | Animal Nutritional Physiological Phenomena - physiology | Cat Diseases - drug therapy | Fish Oils - administration & dosage | Fish Oils - chemistry | Animal Feed | Fatty Acids, Omega-3 - administration & dosage | Fish Oils - therapeutic use
Journal Article
European Journal of Nutrition, ISSN 1436-6207, 6/2013, Volume 52, Issue 4, pp. 1315 - 1325
Biological effects of marine oils, fish oil (FO) and krill oil (KO), are mostly attributed to the high content of n-3 polyunsaturated fatty acids (n-3 PUFAs),...
Chemistry | Nutrition | n-3 PUFA | High-fat diet | Lipids | Krill oil | Inflammation | Fish oil | BETA-OXIDATION | N-3 FATTY-ACIDS | NECROSIS-FACTOR-ALPHA | NUTRITION & DIETETICS | PEROXISOME PROLIFERATION | INSULIN-RESISTANCE | DOCOSAHEXAENOIC ACID | CARDIOVASCULAR-DISEASE | HEALTHY-VOLUNTEERS | EICOSAPENTAENOIC ACID | ADIPOSE-TISSUE | Tumor Necrosis Factor-alpha - metabolism | Humans | Tumor Necrosis Factor-alpha - genetics | Male | Carnitine - metabolism | Eicosapentaenoic Acid - administration & dosage | Oils - therapeutic use | Fish Oils - therapeutic use | Liver - immunology | Phospholipids - blood | Phospholipids - metabolism | Docosahexaenoic Acids - therapeutic use | Euphausiacea - chemistry | Cytokines - metabolism | Hypertriglyceridemia - immunology | Liver - metabolism | Mice, Inbred C57BL | Carnitine - blood | Eicosapentaenoic Acid - metabolism | Lipid Metabolism | Mice, Transgenic | Docosahexaenoic Acids - administration & dosage | Hypertriglyceridemia - blood | Triglycerides - metabolism | Eicosapentaenoic Acid - blood | Hypertriglyceridemia - prevention & control | Animals | Docosahexaenoic Acids - blood | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Hypertriglyceridemia - etiology | Triglycerides - blood | Eicosapentaenoic Acid - therapeutic use | Hypolipidemic Agents - therapeutic use | Mice | Dietary Supplements | Tumor Necrosis Factor-alpha - biosynthesis | Docosahexaenoic Acids - metabolism
Chemistry | Nutrition | n-3 PUFA | High-fat diet | Lipids | Krill oil | Inflammation | Fish oil | BETA-OXIDATION | N-3 FATTY-ACIDS | NECROSIS-FACTOR-ALPHA | NUTRITION & DIETETICS | PEROXISOME PROLIFERATION | INSULIN-RESISTANCE | DOCOSAHEXAENOIC ACID | CARDIOVASCULAR-DISEASE | HEALTHY-VOLUNTEERS | EICOSAPENTAENOIC ACID | ADIPOSE-TISSUE | Tumor Necrosis Factor-alpha - metabolism | Humans | Tumor Necrosis Factor-alpha - genetics | Male | Carnitine - metabolism | Eicosapentaenoic Acid - administration & dosage | Oils - therapeutic use | Fish Oils - therapeutic use | Liver - immunology | Phospholipids - blood | Phospholipids - metabolism | Docosahexaenoic Acids - therapeutic use | Euphausiacea - chemistry | Cytokines - metabolism | Hypertriglyceridemia - immunology | Liver - metabolism | Mice, Inbred C57BL | Carnitine - blood | Eicosapentaenoic Acid - metabolism | Lipid Metabolism | Mice, Transgenic | Docosahexaenoic Acids - administration & dosage | Hypertriglyceridemia - blood | Triglycerides - metabolism | Eicosapentaenoic Acid - blood | Hypertriglyceridemia - prevention & control | Animals | Docosahexaenoic Acids - blood | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Hypertriglyceridemia - etiology | Triglycerides - blood | Eicosapentaenoic Acid - therapeutic use | Hypolipidemic Agents - therapeutic use | Mice | Dietary Supplements | Tumor Necrosis Factor-alpha - biosynthesis | Docosahexaenoic Acids - metabolism
Journal Article
Journal of Pediatric Gastroenterology and Nutrition, ISSN 0277-2116, 10/2010, Volume 51, Issue 4, pp. 514 - 521
OBJECTIVES:Safety, tolerability, and efficacy of a novel lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish...
Lipids | Parenteral nutrition | Vitamin E | Fish oil | Premature birth | lipids | SURGICAL-PATIENTS | OMEGA-3-FATTY-ACIDS | fish oil | vitamin E | PRETERM INFANTS | LIVER-DISEASE | SUPPLEMENTATION | NUTRITION & DIETETICS | premature birth | LEUKOTRIENE SYNTHESIS | parenteral nutrition | POLYUNSATURATED FATTY-ACIDS | PEDIATRICS | GASTROENTEROLOGY & HEPATOLOGY | MAJOR SURGERY | BRAIN | DIETARY LIPIDS | Infant Nutritional Physiological Phenomena | Fat Emulsions, Intravenous - adverse effects | Thinness - drug therapy | Double-Blind Method | Humans | Body Weight - drug effects | Treatment Outcome | Soybean Oil - therapeutic use | Olive Oil | Plant Oils - therapeutic use | Fish Oils - therapeutic use | Triglycerides - administration & dosage | Parenteral Nutrition - methods | Infant, Premature | Soybean Oil - administration & dosage | Fish Oils - administration & dosage | Triglycerides - therapeutic use | Weight Gain - drug effects | Plant Oils - administration & dosage | Fat Emulsions, Intravenous - therapeutic use | Infant, Newborn
Lipids | Parenteral nutrition | Vitamin E | Fish oil | Premature birth | lipids | SURGICAL-PATIENTS | OMEGA-3-FATTY-ACIDS | fish oil | vitamin E | PRETERM INFANTS | LIVER-DISEASE | SUPPLEMENTATION | NUTRITION & DIETETICS | premature birth | LEUKOTRIENE SYNTHESIS | parenteral nutrition | POLYUNSATURATED FATTY-ACIDS | PEDIATRICS | GASTROENTEROLOGY & HEPATOLOGY | MAJOR SURGERY | BRAIN | DIETARY LIPIDS | Infant Nutritional Physiological Phenomena | Fat Emulsions, Intravenous - adverse effects | Thinness - drug therapy | Double-Blind Method | Humans | Body Weight - drug effects | Treatment Outcome | Soybean Oil - therapeutic use | Olive Oil | Plant Oils - therapeutic use | Fish Oils - therapeutic use | Triglycerides - administration & dosage | Parenteral Nutrition - methods | Infant, Premature | Soybean Oil - administration & dosage | Fish Oils - administration & dosage | Triglycerides - therapeutic use | Weight Gain - drug effects | Plant Oils - administration & dosage | Fat Emulsions, Intravenous - therapeutic use | Infant, Newborn
Journal Article
Neurochemistry International, ISSN 0197-0186, 05/2016, Volume 95, pp. 63 - 74
Alzheimer's disease (AD) is a progressive neurodegenerative disorder, characterized by deposition of amyloid plaques and neurofibrillary tangles, as well as...
Lipoic acid | Apigenin | Neuroinflammation | Curcumin | Fish oil | Green tea | Alzheimer's disease | BIOCHEMISTRY & MOLECULAR BIOLOGY | N-3 FATTY-ACIDS | ALPHA-LIPOIC ACID | NEUROSCIENCES | CYTOKINE PRODUCTION | AMYLOID-INDUCED NEUROTOXICITY | DOCOSAHEXAENOIC ACID | ADVANCED GLYCATION ENDPRODUCTS | DOUBLE-BLIND | SOLID LIPID CURCUMIN | PLANT-DERIVED POLYPHENOLS | NF-KAPPA-B | Neuroprotective Agents - therapeutic use | Inflammation - pathology | Stilbenes - therapeutic use | Randomized Controlled Trials as Topic - methods | Humans | Neurodegenerative Diseases - prevention & control | Neurofibrillary Tangles - drug effects | Alzheimer Disease - pathology | Fish Oils - therapeutic use | Inflammation - metabolism | Neurofibrillary Tangles - metabolism | Biological Products - therapeutic use | Neurofibrillary Tangles - pathology | Fish Oils - isolation & purification | Neurodegenerative Diseases - pathology | Curcumin - therapeutic use | Alzheimer Disease - drug therapy | Curcumin - isolation & purification | Neurodegenerative Diseases - metabolism | Biological Products - isolation & purification | Antioxidants - therapeutic use | Animals | Neuroprotective Agents - isolation & purification | Antioxidants - isolation & purification | Stilbenes - isolation & purification | Alzheimer Disease - metabolism | Inflammation - prevention & control | Chronic Disease | Antioxidants | Medical colleges | Unsaturated fatty acids | Catechin | Functional foods | Alternative medicine | Therapeutics | Resveratrol | Omega-3 fatty acids | Homeopathy | Materia medica and therapeutics
Lipoic acid | Apigenin | Neuroinflammation | Curcumin | Fish oil | Green tea | Alzheimer's disease | BIOCHEMISTRY & MOLECULAR BIOLOGY | N-3 FATTY-ACIDS | ALPHA-LIPOIC ACID | NEUROSCIENCES | CYTOKINE PRODUCTION | AMYLOID-INDUCED NEUROTOXICITY | DOCOSAHEXAENOIC ACID | ADVANCED GLYCATION ENDPRODUCTS | DOUBLE-BLIND | SOLID LIPID CURCUMIN | PLANT-DERIVED POLYPHENOLS | NF-KAPPA-B | Neuroprotective Agents - therapeutic use | Inflammation - pathology | Stilbenes - therapeutic use | Randomized Controlled Trials as Topic - methods | Humans | Neurodegenerative Diseases - prevention & control | Neurofibrillary Tangles - drug effects | Alzheimer Disease - pathology | Fish Oils - therapeutic use | Inflammation - metabolism | Neurofibrillary Tangles - metabolism | Biological Products - therapeutic use | Neurofibrillary Tangles - pathology | Fish Oils - isolation & purification | Neurodegenerative Diseases - pathology | Curcumin - therapeutic use | Alzheimer Disease - drug therapy | Curcumin - isolation & purification | Neurodegenerative Diseases - metabolism | Biological Products - isolation & purification | Antioxidants - therapeutic use | Animals | Neuroprotective Agents - isolation & purification | Antioxidants - isolation & purification | Stilbenes - isolation & purification | Alzheimer Disease - metabolism | Inflammation - prevention & control | Chronic Disease | Antioxidants | Medical colleges | Unsaturated fatty acids | Catechin | Functional foods | Alternative medicine | Therapeutics | Resveratrol | Omega-3 fatty acids | Homeopathy | Materia medica and therapeutics
Journal Article
Journal of Parenteral and Enteral Nutrition, ISSN 0148-6071, 8/2014, Volume 38, Issue 6, pp. 711 - 716
Background: Preliminary studies suggest that fish-oil lipid emulsion given parenterally to very preterm infants reduces the severity of retinopathy (ROP) and...
fish oil emulsion | parenteral nutrition | docosahexaenoic acid | Cholestasis | retinopathy of prematurity | very low birth weight infant | PREMATURE-INFANTS | PRETERM INFANTS | TRIAL | NUTRITION & DIETETICS | LIPID EMULSION | PARENTERAL-NUTRITION | OPTIMIZATION | Docosahexaenoic Acids - therapeutic use | Retinopathy of Prematurity - blood | Emulsions - therapeutic use | Prospective Studies | Infant, Very Low Birth Weight | Humans | Male | Treatment Outcome | Soybean Oil - therapeutic use | Olive Oil | Plant Oils - therapeutic use | Fish Oils - therapeutic use | Cholestasis - blood | Cholestasis - prevention & control | Docosahexaenoic Acids - blood | Parenteral Nutrition - methods | Infant, Premature | Female | Retinopathy of Prematurity - prevention & control | Child Development - drug effects | Fat Emulsions, Intravenous - therapeutic use | Phospholipids - therapeutic use | Infant, Newborn
fish oil emulsion | parenteral nutrition | docosahexaenoic acid | Cholestasis | retinopathy of prematurity | very low birth weight infant | PREMATURE-INFANTS | PRETERM INFANTS | TRIAL | NUTRITION & DIETETICS | LIPID EMULSION | PARENTERAL-NUTRITION | OPTIMIZATION | Docosahexaenoic Acids - therapeutic use | Retinopathy of Prematurity - blood | Emulsions - therapeutic use | Prospective Studies | Infant, Very Low Birth Weight | Humans | Male | Treatment Outcome | Soybean Oil - therapeutic use | Olive Oil | Plant Oils - therapeutic use | Fish Oils - therapeutic use | Cholestasis - blood | Cholestasis - prevention & control | Docosahexaenoic Acids - blood | Parenteral Nutrition - methods | Infant, Premature | Female | Retinopathy of Prematurity - prevention & control | Child Development - drug effects | Fat Emulsions, Intravenous - therapeutic use | Phospholipids - therapeutic use | Infant, Newborn
Journal Article
American Journal of Health-System Pharmacy, ISSN 1079-2082, 07/2009, Volume 66, Issue 13, pp. 1169 - 1179
Purpose. The potential therapeutic benefits of supplementation with n-3 polyunsaturated fatty acids (PUFAs) in various diseases are reviewed, and the...
Fish oils | Polyunsaturated fatty acids | Toxicity | Drug interactions | Docosahexaenoic acid | Mechanism of action | Eicosapentaenoic acid | RHEUMATOID-ARTHRITIS | FACTOR-ALPHA PRODUCTION | MONONUCLEAR-CELLS | FISH-OIL SUPPLEMENTATION | TUMOR-NECROSIS-FACTOR | EXERCISE-INDUCED BRONCHOCONSTRICTION | DOUBLE-BLIND | PARENTERAL-NUTRITION | PHARMACOLOGY & PHARMACY | Docosahexaenoic Acids - therapeutic use | Humans | Eicosapentaenoic Acid - adverse effects | Eicosapentaenoic Acid - administration & dosage | Docosahexaenoic Acids - administration & dosage | Fish Oils - adverse effects | Fish Oils - therapeutic use | Dose-Response Relationship, Drug | Animals | Anti-Inflammatory Agents - adverse effects | Drug Interactions | Inflammation - drug therapy | Anti-Inflammatory Agents - therapeutic use | Fatty Acids, Omega-3 - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Fish Oils - administration & dosage | Eicosapentaenoic Acid - therapeutic use | Dietary Supplements | Docosahexaenoic Acids - adverse effects | Fatty Acids, Omega-3 - adverse effects | Fatty Acids, Omega-3 - administration & dosage | Inflammation - physiopathology | Prevention | Unsaturated fatty acids | Care and treatment | Inflammation | Dosage and administration | Health aspects | Index Medicus
Fish oils | Polyunsaturated fatty acids | Toxicity | Drug interactions | Docosahexaenoic acid | Mechanism of action | Eicosapentaenoic acid | RHEUMATOID-ARTHRITIS | FACTOR-ALPHA PRODUCTION | MONONUCLEAR-CELLS | FISH-OIL SUPPLEMENTATION | TUMOR-NECROSIS-FACTOR | EXERCISE-INDUCED BRONCHOCONSTRICTION | DOUBLE-BLIND | PARENTERAL-NUTRITION | PHARMACOLOGY & PHARMACY | Docosahexaenoic Acids - therapeutic use | Humans | Eicosapentaenoic Acid - adverse effects | Eicosapentaenoic Acid - administration & dosage | Docosahexaenoic Acids - administration & dosage | Fish Oils - adverse effects | Fish Oils - therapeutic use | Dose-Response Relationship, Drug | Animals | Anti-Inflammatory Agents - adverse effects | Drug Interactions | Inflammation - drug therapy | Anti-Inflammatory Agents - therapeutic use | Fatty Acids, Omega-3 - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Fish Oils - administration & dosage | Eicosapentaenoic Acid - therapeutic use | Dietary Supplements | Docosahexaenoic Acids - adverse effects | Fatty Acids, Omega-3 - adverse effects | Fatty Acids, Omega-3 - administration & dosage | Inflammation - physiopathology | Prevention | Unsaturated fatty acids | Care and treatment | Inflammation | Dosage and administration | Health aspects | Index Medicus
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2014, Volume 2, Issue 2, p. CD006320
Background The anti-inflammatory effects of n-3 (omega-3 fatty acids, fish oil) have been suggested to be beneficial in chronic inflammatory disorders such as...
DIETARY-FAT | Humans | N-3 FATTY-ACIDS | MODEL | Fatty Acids, Omega-3 [therapeutic use] | Remission Induction | Randomized Controlled Trials as Topic | Recurrence [prevention & control] | SUPPLEMENTATION | MEDICINE, GENERAL & INTERNAL | INFLAMMATORY-BOWEL-DISEASE | Fish Oils [therapeutic use] | RECOMMENDATIONS | Crohn Disease [diet therapy] | DOUBLE-BLIND | OMEGA-3 | Adult | ACTIVITY INDEX | Child | EICOSAPENTAENOIC-ACID | Fatty Acids, Omega-3 - therapeutic use | Crohn Disease - diet therapy | Secondary Prevention | Fish Oils - therapeutic use
DIETARY-FAT | Humans | N-3 FATTY-ACIDS | MODEL | Fatty Acids, Omega-3 [therapeutic use] | Remission Induction | Randomized Controlled Trials as Topic | Recurrence [prevention & control] | SUPPLEMENTATION | MEDICINE, GENERAL & INTERNAL | INFLAMMATORY-BOWEL-DISEASE | Fish Oils [therapeutic use] | RECOMMENDATIONS | Crohn Disease [diet therapy] | DOUBLE-BLIND | OMEGA-3 | Adult | ACTIVITY INDEX | Child | EICOSAPENTAENOIC-ACID | Fatty Acids, Omega-3 - therapeutic use | Crohn Disease - diet therapy | Secondary Prevention | Fish Oils - therapeutic use
Journal Article